Professional Documents
Culture Documents
a. Wasley will report the dividends received of $6,600 (6,000 shares × $1.10 per share)
as income. If the investment is accounted for as available-for-sale, the increase in
the market price of the stock will not be recognized as income until the stock is sold.
Unrealized gains (losses) are reported as Other Comprehensive Income in the
stockholders’ equity section of the balance sheet.
b. If the investment is accounted for as “trading,” Wasley will report $6,600 of dividend
income plus income relating to the increase in the market price of the stock of
$6,000 ($13 - $12 price increase for 6,000 shares).
E12-25.
P12-45.
c. Realized gains (losses) are gains (losses) that occur as a result of sales of
securities. These are reported in the income statement and affect reported income.
Unrealized gains (losses) reflect the difference between the current market price of
the security and its acquisition cost. Only unrealized gains (losses) from trading
securities are reported in income. If MetLife had sold all of the AFS securities on
which it had gains, its pre-tax income would have increased by $30,757 million.
E12-33.
a. No entry is required when the options are granted. The compensation expense is
recognized ratably over the vesting period. As the options vest, the following entry is
required (assume one-third vested in 2014):
b. Granted stock options (whether vested or not) are included in the denominator of
diluted EPS whenever the stock price is greater than the exercise price. These
options would reduce diluted EPS but have no effect on basic EPS.
The details of the credit to contributed capital would depend on where the shares
came from. If they had been held as treasury shares, the credit would have been to
the treasury shares contra asset, with either a debit or credit in additional paid-in
capital. If the shares were newly issued, the credit would have been to the par value
and additional paid-in capital for Merck’s common stock.
d. When options are exercised, the number of outstanding shares increases. This
would reduce basic EPS. It might also lower diluted EPS, though most likely to a
lesser degree. This is because the dilutive effect may already be reflected in diluted
EPS prior to exercise.
M11-36.
P11-56.
a.
Balance Sheet Income Statement
Cash Noncash Liabil- Contrib. Earned Contra Net
Transaction Asset + Assets = ities + Capital + Capital - Equity Revenues - Expenses = Income
Purchased -100,000 = - +100,0001 - =
10,000 shares Cash Treasury
of treasury Stock
stock for cash.
c.
+ Cash (A) - - Common Stock (SE) +
10/12 18,000 100,000 9/1 25,000 11/21
11/21 55,000
12/28 10,800
+ Treasury Stock (XSE) - - Additional Paid-in Capital (SE) +
9/1 100,000 15,000 10/12 12/28 1,200 3,000 10/12
12,000 12/28 30,000 11/21
e.
Stockholders’ Equity
Paid-in capital
7% Preferred stock, $100 par value, 20,000 shares authorized;
5,000 shares issued and outstanding $500,000
Common stock, $5 par value, 300,000 shares authorized;
125,000 shares issued, of which 7,300 shares are in
the treasury 625,000 $1,125,000
Additional paid-in capital
Paid-in capital in excess of par value—Preferred stock 24,000
Paid-in capital in excess of par value—Common stock 390,000
Paid-in capital from treasury stock 1,800 415,800
Total paid-in capital 1,540,800
Retained earnings 408,000
1,948,800
Less: Treasury stock (7,300 common Shares) at cost 73,000
Total stockholders' equity $1,875,800
f. Because Sougiannis did not pay the 7% dividend on its preferred stock, ROCE is
computed as follows: